Development of a mass spectrometry method for the determination of a melanoma biomarker, 5-S-cysteinyldopa, in human plasma using solid phase extraction for sample clean-up

Journal of Chromatography A

Volumn 1156, Issue 1-2 SPEC. ISS., 2007, Pages 141-148

  Martin, Gaëlle B ^a   Chiap, Patrice ^b   Paquet, Philippe ^b   Pierard, Gerald ^b   de Tullio, Pascal ^a   Martin, Yves ^a   Rozet, Eric ^a   Hubert, Philippe ^a   Crommen, Jacques ^a   Fillet, Marianne ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

5 S cysteinyldopa; HPLC MS; Melanoma marker; Plasma

Indexed keywords

ELECTROSPRAY IONIZATION; EXTRACTION; ION EXCHANGE; MASS SPECTROMETRY; PIGMENTS; PLASMA (HUMAN); SKIN; TUMORS;

DISPOSABLE CARTRIDGES; GRADIENT ELUTION; MELANOMA MARKERS; MULTIPLE REACTION MONITORING (MRM); SOLID PHASE EXTRACTION (SPE);

BIOMARKERS;

BENZENEBORONIC ACID; BIOLOGICAL MARKER; CATECHOLAMINE; CYSTEINYLDOPA;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHEMICAL STRUCTURE; DISEASE MARKER; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MELANOMA; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINYLDOPA; HUMANS; MASS SPECTROMETRY; MELANOMA; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 34250749856     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2006.12.088     Document Type: Article

References (32)

1. Hartleb J., and Arndt R. J. Chromatogr. B 764 (2001) 409
2. Buzaid A.C., Ross M.I., Balch L.M., Soong S.J., Mc Carthy W.H., Tinoco L., et al. J. Clin. Oncol. 15 (1997) 1039
3. O'Day S., and Boasberg P. Surg. Oncol. Clin. N. Am. 15 (2006) 419
4. Cummins D.L., Cummins J.M., Pantle H., Silverman M.A., Leonard A.L., and Chanmugam A. Mayo. Clin. Proc. 81 (2006) 500
5. Brochez L., and Naeyaert J.-M. Br. J. Dermatol. 143 (2000) 256
6. Peterson L.L., Woodward W.R., Fletcher W.S., Palmquist M., Tucker M.A., and Nias A. J. Am. Acad. Dermatol. 19 (1988) 509
7. Wakamatsu K., Kageshita T., Furue M., Hatta N., Kiyohara Y., Ono T., Saida T., Takata M., Tushida T., Uhara H., Yamamoto A., Yamazaki N., Naito A., and Ito S. Melanoma Res. 12 (2002) 245
8. Banfalvi T., Gilde K., Gergye M., Boldizsar M., Kremmer T., and Otto S. Eur. J. Cancer 39 (2003) 164
9. Wimmer I., Meyer J.C., Seifert B., Dummer R., Flace A., and Burg G. Cancer Res. 57 (1997) 5073
10. Hansson C., Edholm L.-E., Agrup G., Rorsman H., Rosengren A.-M., and Rosengren E. Clin. Chim. Acta 88 (1978) 419
11. Kagedal B., and Pettersson A. J. Chromatogr. 272 (1983) 287
12. Hu F., Woodward W.R., and Peterson L.L. J. Investig. Dermatol. 90 (1988) 149
13. Ito S., Kato T., Maruta K., Fujita K., and Kurahashi T. J. Chromatogr. 311 (1984) 154
14. Arstrand K., Kullman A., Andersson R., Rasmuson T., and Kagedal B. Scand. J. Clin. Lab. Invest. 64 (2004) 559
15. Hansson C., Kagedal B., and Kallberg M. J. Chromatogr. 420 (1987) 146
16. Hartleb J., Damm Y., Arndt R., Christophers E., and Stockfleth E. J. Chromatogr. B 727 (1999) 31
17. Huang T., Wall J., and Kabra P. J. Chromatogr. 452 (1988) 409
18. Banfalvi T., Gilde K., Boldizsar M., Fejös Z., Horvath B., Liszkay G., Beczassy E., and Kremmer T. Eur. J. Clin. Investig. 30 (2000) 900
19. Wakamatsu K., and Ito S. Clin. Chem. 40 (1994) 495
20. Kagedal B., Kallberg M., Arstrand K., and Hansson C. J. Chromatogr. 473 (1989) 359
21. Wakamatsu K., Yokochi M., Naito A., Kageshita T., and Ito S. Melanoma Res. 13 (2003) 357
22. Banfalvi T., Gilde K., Boldizsar M., Fejos Z., Horvath B., Liszkay G., Beczassy E., and Kremmer T. Eur. J. Clin. Investig. 30 (2000) 900
23. Arstrand K., Kullman A., Andersson R., Rasmuson T., and Kagedal B. Scand. J. Clin. Lab. Investig. 64 (2004) 559
24. Prota G., Scherillo G., and Nicolaus R.A. Gazz. Chim. Ital. 98 (1968) 495
25. Ito S., Inoue S., Yamamoto Y., and Fujita K. J. Med. Chem. 24 (1981) 673
26. d'Ischia M., Pezzella A., Favretto D., Traldi P., and Prota G. J. Mass Spectrom. 31 (1996) 885
27. Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. STP Pharma Pratiques 13 (2003) 101
28. Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. J. Pharm. Biomed. Anal. 36 (2004) 579
29. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May 2001.
30. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. STP Pharma Pratiques 16 (2006) 30
31. Hubert Ph., Chiap P., Crommen J., Boulanger B., Chapuzet E., Mercier N., Bervoas-Martin S., Chevalier P., Grandjean D., Lagorce P., Lallier M., Laparra M.C., Laurentie M., and Nivet J.C. Anal. Chim. Acta 391 (1999) 135
32. ISO 5725-1, Application of the Statistics-Accuracy (Trueness and Precision) of the Results and Methods of Measurement-Part 1: General Principles and Definitions, International Organization for Standardization (ISO), Geneva, Switzerland.